Literature DB >> 20411337

RNA inference-mediated caveolin-1 down-regulation decrease estrogen receptor alpha (ERα) signaling in human mammary epithelial cells.

Xi Wang1, Shuang Feng, Hong Zhang, Yang Wang, Yuying Cui, Zhaoyi Wang, Jing Liu, Wei Zou.   

Abstract

Several evidences support that caveolin-1 is associated with mammary cell transformation and oncogenesis. We have previously reported that a cell line, named MCF10A-ST1 (ST1), which only expressed 30% Cav-1 compared with parental cells MCF10A (human mammary epithelial cell line) was isolated by gene trapping. The decreased expression of Cav-1 is sufficient for phenotypic transformation of MCF10A cells, which involved in the loss of anchorage-dependent growth and migration in nude mice with the existence of E2. The previous study in our lab on microarray assay showed that the expression of cyclin D1 (cell cycle protein) was up-regulated in ST1 cell line. Here, we not only confirmed the results by Western Blot but also demonstrated that Cav-1 down-regulation accelerate the progression of mammary cells from G1 phase into S phase by Flow Cytometry (FCM). This proposed that the Cav-1 down-regulation could change the progress of cell cycle in the mammary cells. Otherwise, microarray assay also showed that the transcription factor (c-Jun) was up-regulated. But, the original carcinoma gene (c-Fos) and transcription factor (AP-1) have not obviously changed compared with MCF10A. ST1 cells obtained the morigenicity in nude mice with the existence of E2, and the immunoprecipitation showed the interactions of Cav-1 with ERα in both MCF10A and ST1. ERα expression was increased as further down-regulation of Cav-1. So, we hypothesize that Cav-1 down-regulation could induce the activation of ERα-associated signaling pathway, in order to adjust the development and proliferation. By siRNA technology, the down regulation of Cav-1 could activate MAP kinase and Akt signaling pathway, including the phosphorylation of ERK1/2 and Akt. However, the mechanism of Cav-1 down-regulation in the early transformation and signaling transduction of mammary epithelial cells is unclear. Here, we report that down-regulation of caveolin-1 protein expression leads to deregulate estrogen receptor alpha (ERα) signaling and consequently early transformation in mammary epithelia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20411337     DOI: 10.1007/s11033-010-0164-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  33 in total

1.  Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.

Authors:  Tianhong Li; Federica Sotgia; Magalis A Vuolo; Maomi Li; Wan Cai Yang; Richard G Pestell; Joseph A Sparano; Michael P Lisanti
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 2.  The regulation of AP-1 activity by mitogen-activated protein kinases.

Authors:  M Karin
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

3.  Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor.

Authors:  R Yao; G M Cooper
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

4.  Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer.

Authors:  M Razandi; A Pedram; E R Levin
Journal:  Mol Endocrinol       Date:  2000-09

5.  Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol.

Authors:  Filippo Acconcia; Paolo Ascenzi; Alessio Bocedi; Enzo Spisni; Vittorio Tomasi; Anna Trentalance; Paolo Visca; Maria Marino
Journal:  Mol Biol Cell       Date:  2004-10-20       Impact factor: 4.138

6.  FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas.

Authors:  Karin Milde-Langosch; Holger Kappes; Sabine Riethdorf; Thomas Löning; Ana-Maria Bamberger
Journal:  Breast Cancer Res Treat       Date:  2003-02       Impact factor: 4.872

7.  Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage.

Authors:  E Passegué; W Jochum; M Schorpp-Kistner; U Möhle-Steinlein; E F Wagner
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

8.  Caveolae: biochemical analysis.

Authors:  Christian Chatenay-Rivauday; Z Petek Cakar; Paul Jenö; Elena S Kuzmenko; Klaus Fiedler
Journal:  Mol Biol Rep       Date:  2004-06       Impact factor: 2.316

9.  Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells.

Authors:  Dragoslava Zivadinovic; Cheryl S Watson
Journal:  Breast Cancer Res       Date:  2004-11-26       Impact factor: 6.466

Review 10.  Caveolae structure and function.

Authors:  Candice M Thomas; Eric J Smart
Journal:  J Cell Mol Med       Date:  2008-02-27       Impact factor: 5.310

View more
  5 in total

1.  Uterine cysts in female mice deficient for caveolin-1 and insulin-like 3 receptor RXFP2.

Authors:  Zhen Li; Shu Feng; Vanessa Lopez; Gina Elhammady; Matthew L Anderson; Elena M Kaftanovskaya; Alexander I Agoulnik
Journal:  Endocrinology       Date:  2011-04-05       Impact factor: 4.736

2.  RNAi assay in primary cells: a new method for gene function analysis in marine bivalve.

Authors:  Yanan You; Pin Huan; Baozhong Liu
Journal:  Mol Biol Rep       Date:  2012-04-28       Impact factor: 2.316

3.  Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells.

Authors:  Dan Shi; Yan Liu; Ronggang Xi; Wei Zou; Lijun Wu; Zhiran Zhang; Zhongyang Liu; Chao Qu; Baoli Xu; Xiaobo Wang
Journal:  Int J Nanomedicine       Date:  2016-11-07

4.  Choline plasmalogens isolated from swine liver inhibit hepatoma cell proliferation associated with caveolin-1/Akt signaling.

Authors:  Yaoyao Zhan; Liang Wang; Jing Liu; Keli Ma; Cuiping Liu; Yuan Zhang; Wei Zou
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

5.  Caveolin-1 facilitated KCNA5 expression, promoting breast cancer viability.

Authors:  Chao Qu; Jia Sun; Ying Liu; Xiaobo Wang; Lifen Wang; Chao Han; Qian Chen; Tianhui Guan; Hongyan Li; Yejun Zhang; Yang Wang; Jia Liu; Wei Zou; Jing Liu
Journal:  Oncol Lett       Date:  2018-08-03       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.